2007
DOI: 10.1080/10731190600974582
|View full text |Cite
|
Sign up to set email alerts
|

One-Year Observation of Wistar Rats after Intravenous Infusion of Hemoglobin-Vesicles (Artificial Oxygen Carriers)

Abstract: Hemoglobin-vesicles (HbV) or liposome-encapsulated Hb are artificial oxygen carriers. Our previous studies of the bolus infusion of HbV into Wistar rats showed that HbV was captured by the reticuloendothelial system from the blood stream and degraded completely with no deteriorative effect for 2 weeks. However, one authority on artificial organs research suggested conducting a one-year observation because he experienced, with one lipid-emulsified perfluorocarbon (PFC), that rats died within one year from a pul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 18 publications
0
7
0
Order By: Relevance
“…The most common lipid used to partially form the membrane of PEG-LEHs consists of dipalmitoylphosphatidylcholine (DPPC). Unfortunately, DPPC has a phase transition temperature of 41°C, 810, 1418, 25, 28, 29, 3439 which is close to the core body temperature (37°C). Therefore, transfusion of DPPC containing PEG-LEHs will result in increased PEG-LEH membrane fluidity, which will eventually lead to liposomal membrane destabilization and subsequent release of free Hb into the blood stream.…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…The most common lipid used to partially form the membrane of PEG-LEHs consists of dipalmitoylphosphatidylcholine (DPPC). Unfortunately, DPPC has a phase transition temperature of 41°C, 810, 1418, 25, 28, 29, 3439 which is close to the core body temperature (37°C). Therefore, transfusion of DPPC containing PEG-LEHs will result in increased PEG-LEH membrane fluidity, which will eventually lead to liposomal membrane destabilization and subsequent release of free Hb into the blood stream.…”
Section: Resultsmentioning
confidence: 98%
“…810, 1418, 25, 28, 29, 3439 Scale up of this process is challenging, as it requires large ultracentrifuges capable of attaining high speeds (100,000–200,000 g ). In this work, TFF using HF cartridges of a defined molecular weight cut off (500 kDa) were used to completely remove all unencapsulated Hb and concentrate the final PEG-LEH dispersion.…”
Section: Resultsmentioning
confidence: 99%
“…The injected volume of HbV (2000 mg Hb/kg, 20 mL/kg) is the same as our previous safety and toxicology studies of HbV using rodent 7,8,14) that corresponded to nearly 28% of mouse blood volume (72 mL/ kg). 15) At days 1, 3, 7 and 14 after the HbV injection, five mice were randomly selected from each group for collection of blood and organs.…”
Section: Animalsmentioning
confidence: 99%
“…The transport capacity of O 2 by HbV is equivalent to that for RBC, and HbV shows resuscitative effects that are comparable to RBC in hemorrhagic shock rat models [57]. In addition, HbV has been shown to be safe and biocompatible based on in vitro and in vivo experiments as follows: the absence of viral contamination [8], high biocompatibility in systemic immune responses [9], no innate toxicity [1012], readily metabolized and excreted under both healthy and pathological conditions [1315]. Furthermore, the structure and physicochemical characteristics of HbV in the liquid state remain about the same during storage for periods of over 1 year at 4, 23, and 40°C, indicating that a HbV suspension can be stored at room temperature for at least 1 year [16].…”
Section: Introductionmentioning
confidence: 99%